Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that its genome-based ...

New research using fruit flies reveals that Alzheimer’s disease impacts not just the brain, but the entire body. Alzheimer’s ...

This breakthrough gives clinicians the ability to identify aortic valve disease earlier in its course, allowing for timely interventions and improved patient outcomes. The AI-ECG algorithm was ...

EMJ spoke with Arnold Seto, a leading interventional cardiologist, to discuss innovations in vascular access, procedural ...

Artificial intelligence is playing an increasingly vital role in modern medicine, particularly in interpreting medical images ...

A team at the University of California, Los Angeles has developed a low-cost diagnostic pen that converts handwriting into ...

A novel screening approach developed by physicians at the Lewis Katz School of Medicine at Temple University shows ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced that its genome-based Signatera MRD assay is now covered by Medicare under LCD L38779. This coverage decision ...

The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk.